Skip to main content

20 October 2026

Last updated: Tuesday 20 October 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Oxford Capital Partners assesses the funding outlook

Wednesday 10 September 2008

Interviewee/Contributor

David Mott

Organisation

Oxford Capital Partners Ltd

Organisations

Cereno Scientific AB
Paul Capital Healthcare
Society for Family Health Nigeria
Diurnal Group Plc
International Society for Cell and Gene Therapy
Mind Medicine Inc
Amyl Therapeutics BV
AstraZeneca Plc
Marks & Clerk Solicitors LLP
ISA Pharmaceuticals BV

Interviewees and Contributers

Jasper Bos
Dr Matthew Wright
Femida Gwadry-Sridhar
Pierre Belichard
Massimo Dominici
John Rountree
Eric Castaldi
Madhusudan Peshwa
Gabriele Campi
Johan Christenson

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Orano Med appoints CSO

Tuesday 20 October 2026

Evotec appoints CSO

Thursday 15 October 2026

New CEO at AL-S Pharma

Wednesday 14 October 2026

Bavarian Nordic appoints new CEO

Monday 12 October 2026

Leadership transition at Nuclera

Monday 12 October 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form